About Valneva SE


  • Ticker VALN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,103,504
  • Market Cap $305M
  • Description
  • Valneva SE, a specialty vaccine company, focuses on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. Its commercial vaccines for travelers include IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; ...
More about VALN
Track This Portfolio

Track General American Investors CO Inc Portfolio

Follow General American Investors CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of General American Investors CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on General American Investors CO Inc with notifications on news.